Starget Pharma

Company Overview

Snapshot

Founded in July 2019 by Sigal Kalmanson Cusnir and Ronen Kalmanson, Starget Pharma operates with 11–50 employees. The company has secured funding across three rounds and was recognized as one of the Most Innovative Life Science Startups at Biomed Israel in May 2026.

Business overview

Starget Pharma is a Health Tech & Life Sciences company focused on the diagnosis and targeted treatment of cancer. The company develops molecules that act as vectors to selectively deliver imaging materials and treatments directly to tumor tissue, leveraging a novel somatostatin-based targeted therapy platform. Starget Pharma operates within the Pharma & Medical Biotechnology sector, specifically in Drug Delivery and Test Diagnostics & Screening, serving the Life Sciences and Pharmaceuticals markets.

Strategic signal

In February 2026, Starget Pharma announced its plans to launch advanced trials for a first-of-its-kind sarcoma treatment in collaboration with MD Anderson. This collaboration signifies a major validation of Starget Pharma's therapeutic approach and its potential to address critical unmet needs in oncology, positioning the company for significant clinical and commercial advancement.

Company Intelligence Q&A

What was a significant recent recognition for Starget Pharma?

In May 2026, Starget Pharma was awarded as one of the.

What is Starget Pharma's recent strategic collaboration?

In February 2026, Starget Pharma announced a collaboration with MD Anderson to launch advanced trials for a novel sarcoma treatment.

What was a key funding event for Starget Pharma in 2024?

In October 2024, Starget Pharma received a $5.1M investment from Cancer Focus Fund.

What is Starget Pharma's core technology focus?

Starget Pharma focuses on developing molecules that serve as vectors for selectively transferring imaging materials and treatments directly to tumor tissue, utilizing an AI-based discovery platform for new radiotherapy drugs.

Who are the founders of Starget Pharma?

Starget Pharma was co-founded by Sigal Kalmanson Cusnir and Ronen Kalmanson in July 2019.